AMAG PHARMACEUTICALS, INC. 4/A SEC Filings

Filed On	Filing
17 Jun 2015	Form 4/A: Holmes Scott A, SVP, Finance and Treasurer Received 22,516 shares by exercise or conversion ($370K) · Acquired 22,516 Stock Option (Right to Buy) (Option Exercise/Conversion)
03 Jan 2013	Form 4/A: Madison Greg, EVP, Chief Commerical Officer Granted 75,000 Stock Option · Granted 35,000 Restricted Stock Unit
25 May 2012	Form 4/A: Russell Lesley, Director Granted 3,800 Stock Options · Granted 2,300 Restricted Stock Units
25 May 2012	Form 4/A: Bonventre Joseph Vincent, Director Granted 3,800 Stock Options · Granted 2,300 Restricted Stock Units
25 May 2012	Form 4/A: Perez Robert J, Director Granted 3,800 Stock Options · Granted 2,300 Restricted Stock Units
10 Jan 2012	Form 4/A: Farmer Joseph L, SVP, General Counsel Received 8,000 shares by conversion · Sold 8,000 shares ($137K) · Acquired 8,000 Restricted Stock Units (Derivative Conversion)
01 Jun 2011	Form 4/A: Arkowitz David, EVP, CFO, CBO Bought 1,500 shares ($19.8K)
19 Jun 2006	Form 4/A: Roberts Edward B, Director Sold 8,000 shares ($204K)
29 Jul 2004	Form 4/A: Pereira Brian Jg, Director Granted 15,000 Stock option (right to buy)

Comments